SELECT COUNTRY

VIEW ALL
AFRICA
AMERICAS
ASIA
EUROPE
OCEANIA

UNITED STATES: LATEST INTERVIEWS MORE INTERVIEWS

Ben Bradford
HEAD OF EXTERNAL AFFAIRS, MASSBIO
"It is the Massachusetts story — early-stage companies developing great science, commercial giants with a local presence, and financial partnerships that turn ideas into treatments."
United States
Pharma & Life Sciences
Tim Scott
PRESIDENT AND CEO, BIOCOM CALIFORNIA
"We have recognized the synergies between the life science and tech industries, and have worked to foster relationships that can accelerate therapeutic, medical device and diagnostic development."
United States
Pharma & Life Sciences
Eddie Pauline
PRESIDENT AND CEO, OHIO LIFE SCIENCES
"Ohio is increasingly competitive in attracting larger, well-known life science brands, plus our institutions continue to spin out new biotech companies; people across the country are starting to notice."
United States
Pharma & Life Sciences
Takahiro Ueda
CEO, CMIC CMO USA
"Continuous manufacturing is key to our US strategy, differentiating us in the market."
United States
Pharma & Life Sciences

MACIG

SPANISH

SUBSCRIBE TO OUR NEWSLETTER

RECENT PUBLICATIONS

United States Life Sciences 2025 - Digital Interactive

Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
MORE PREVIOUSLY PUBLISHED

PARTNER EVENTS

SEE ALL